rs878854488
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_002354.3(EPCAM):c.429G>A(p.Trp143*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000344 in 1,453,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002354.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Lynch syndrome 8Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital diarrhea 5 with tufting enteropathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002354.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPCAM | NM_002354.3 | MANE Select | c.429G>A | p.Trp143* | stop_gained | Exon 4 of 9 | NP_002345.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPCAM | ENST00000263735.9 | TSL:1 MANE Select | c.429G>A | p.Trp143* | stop_gained | Exon 4 of 9 | ENSP00000263735.4 | ||
| EPCAM | ENST00000405271.5 | TSL:5 | c.513G>A | p.Trp171* | stop_gained | Exon 5 of 10 | ENSP00000385476.1 | ||
| EPCAM | ENST00000456133.5 | TSL:5 | n.513G>A | non_coding_transcript_exon | Exon 5 of 11 | ENSP00000410675.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251230 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1453182Hom.: 0 Cov.: 29 AF XY: 0.00000553 AC XY: 4AN XY: 723494 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, truncating variants in EPCAM are known to be pathogenic (PMID: 24142340). This sequence change creates a premature translational stop signal at codon 143 (p.Trp143*). It is expected to result in an absent or disrupted protein product. Exon level deletions at the 3' end of EPCAM, involving exon 9 minimally, lead to transcriptional read-through into the neighboring MSH2 gene, triggering epigenetic silencing and inactivation of MSH2 (PMID: 19098912, 23938213). Loss of MSH2 subsequently causes Lynch syndrome (PMID: 23264089, 19455606, 15849733). Other pathogenic sequence changes, such as this variant c.429G>A p.Trp143*, which disrupt EPCAM protein function alone, are known causes of autosomal recessive congenital tufting enteropathy (PMID: 18572020, 20034091, 23462293).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at